Unicycive Therapeutics, Inc. (UNCY)
NASDAQ: UNCY · Real-Time Price · USD
7.05
+0.46 (6.98%)
At close: Mar 9, 2026, 4:00 PM EDT
6.88
-0.17 (-2.41%)
After-hours: Mar 9, 2026, 7:14 PM EDT
Unicycive Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2018 |
| Cash & Equivalents | 42.7 | 26.14 | 9.7 | 0.46 | 16.58 | - | Upgrade
|
| Cash & Short-Term Investments | 42.7 | 26.14 | 9.7 | 0.46 | 16.58 | - | Upgrade
|
| Cash Growth | 31.99% | 169.48% | 2032.09% | -97.26% | - | - | Upgrade
|
| Prepaid Expenses | 6.71 | 3.87 | 3.37 | 2.03 | 1.71 | - | Upgrade
|
| Other Current Assets | 0.88 | 0.94 | 0.33 | 0.16 | 0.13 | 0.2 | Upgrade
|
| Total Current Assets | 50.29 | 30.95 | 13.4 | 2.64 | 18.41 | 0.2 | Upgrade
|
| Property, Plant & Equipment | 0.32 | 0.72 | 0.79 | 0.17 | 0.33 | - | Upgrade
|
| Total Assets | 50.61 | 31.67 | 14.19 | 2.82 | 18.74 | 0.2 | Upgrade
|
| Accounts Payable | 0.96 | 1.06 | 0.84 | 0.89 | 0.74 | 0.18 | Upgrade
|
| Accrued Expenses | 2.76 | 3.56 | 3.23 | 2.24 | 1.21 | 0.18 | Upgrade
|
| Short-Term Debt | - | - | - | - | - | 2.51 | Upgrade
|
| Current Portion of Leases | 0.27 | 0.56 | 0.33 | 0.16 | 0.15 | - | Upgrade
|
| Other Current Liabilities | 9.15 | 18.94 | 13.13 | - | - | - | Upgrade
|
| Total Current Liabilities | 13.13 | 24.12 | 17.53 | 3.28 | 2.11 | 2.88 | Upgrade
|
| Long-Term Leases | - | 0.12 | 0.47 | - | 0.16 | - | Upgrade
|
| Total Liabilities | 13.13 | 24.24 | 18 | 3.28 | 2.26 | 2.88 | Upgrade
|
| Common Stock | 0.02 | 0.11 | 0.04 | 0.02 | 0.02 | 0.01 | Upgrade
|
| Additional Paid-In Capital | 150.62 | 108.59 | 60.7 | 33.52 | 32.41 | 3.24 | Upgrade
|
| Retained Earnings | -113.16 | -101.27 | -64.54 | -34 | -15.94 | -5.92 | Upgrade
|
| Shareholders' Equity | 37.48 | 7.43 | -3.81 | -0.47 | 16.48 | -2.67 | Upgrade
|
| Total Liabilities & Equity | 50.61 | 31.67 | 14.19 | 2.82 | 18.74 | 0.2 | Upgrade
|
| Total Debt | 0.27 | 0.68 | 0.79 | 0.16 | 0.31 | 2.51 | Upgrade
|
| Net Cash (Debt) | 42.43 | 25.46 | 8.91 | 0.3 | 16.27 | -2.51 | Upgrade
|
| Net Cash Growth | 34.53% | 185.82% | 2869.33% | -98.16% | - | - | Upgrade
|
| Net Cash Per Share | 3.22 | 3.80 | 3.63 | 0.20 | 13.94 | -2.96 | Upgrade
|
| Filing Date Shares Outstanding | 21.49 | 11.97 | 3.48 | 1.52 | 1.5 | 0.89 | Upgrade
|
| Total Common Shares Outstanding | 20.85 | 11.38 | 3.48 | 1.52 | 1.5 | 0.85 | Upgrade
|
| Working Capital | 37.16 | 6.83 | -4.14 | -0.64 | 16.31 | -2.67 | Upgrade
|
| Book Value Per Share | 1.80 | 0.65 | -1.10 | -0.31 | 10.99 | -3.14 | Upgrade
|
| Tangible Book Value | 37.48 | 7.43 | -3.81 | -0.47 | 16.48 | -2.67 | Upgrade
|
| Tangible Book Value Per Share | 1.80 | 0.65 | -1.10 | -0.31 | 10.99 | -3.14 | Upgrade
|
| Machinery | 0.07 | 0.06 | 0.02 | 0.01 | 0.01 | - | Upgrade
|
| Construction In Progress | - | 0.01 | - | - | - | - | Upgrade
|
| Leasehold Improvements | 0.07 | 0.05 | 0.02 | 0.02 | 0.02 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.